Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | CA9 | Q16790 | 1/20 | 0.41 |
| ▸ | CRBN | Q96SW2 | 3/20 | 0.38 |
| ▸ | CASP1 | P29466 | 1/20 | 0.38 |
| ▸ | CASP7 | P55210 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.37 |
| ▸ | CALCRL | Q16602 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14530505 | 0.92 | TDP1 (0.41) | TSHRTDP1CA9CASP1CASP7 | |
| SCHEMBL14536414 | 0.92 | CALCRL (0.43) | TSHRTDP1CA9CASP1CASP7 | |
| SCHEMBL1714787 | 0.92 | TDP1 (0.41) | TSHRTDP1CA9CASP1CASP7 | |
| SCHEMBL1715181 | 0.92 | CALCRL (0.43) | TSHRTDP1CA9CASP1CASP7 | |
| Hydrochloric Acid SCHEMBL1714778 | 0.91 | CALCRL (0.42) | TSHRTDP1CA9CASP1CASP7 | |
| SCHEMBL16659357 | 0.81 | TSHR (0.42) | TSHRTDP1CRBNAKR1B1CALCRL | |
| SCHEMBL380001 | 0.81 | CALCRL (0.41) | TSHRTDP1CA9CRBNCASP1 | |
| SCHEMBL12199729 | 0.80 | TSHR (0.57) | TSHRTDP1CRBNAKR1B1MAPT | |
| SCHEMBL16659358 | 0.78 | ALDH1A1 (0.53) | TSHRTDP1CRBNCALCRLKDM4E | |
| SCHEMBL16659373 | 0.77 | CRBN (0.45) | TSHRTDP1CRBNCALCRLMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9296750-B2 | Spirolactam CGRP receptor antagonists | MERCK SHARP & DOHME CORP. (US) | 2016-03-29 | — | — | US | disclosed |
| US-20150111914-A1 | SPIROLACTAM CGRP RECEPTOR ANTAGONISTS | MERCK SHARP & DOHME LLC | 2015-04-23 | — | — | US | disclosed |
| US-20110245240-A1 | CGRP RECEPTOR ANTAGONISTS | MERCK SHARP & DOHME CORP. | 2011-10-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110245240-A1 | CGRP RECEPTOR ANTAGONISTS | CCKAR, CALCRL, QRFPR | TSHR 325/4885TDP1 3318/4885CA9 1947/4885 |
| US-20150111914-A1 | SPIROLACTAM CGRP RECEPTOR ANTAGONISTS | CALCRL, CALCR, TACR1 | TSHR 762/4885TDP1 2415/4885CA9 1498/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.